Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a ...

When Twist Bioscience last reported its March 2025 balance sheet in May 2025, it had zero debt and cash worth US$257m. Importantly, its cash burn was US$65m over the trailing twelve months.

Twist Bioscience Twist Bioscience is a synthetic biology company that has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience works in the ...

How Well Is Twist Bioscience Growing? We reckon the fact that Twist Bioscience managed to shrink its cash burn by 31% over the last year is rather encouraging. And considering that its operating ...

Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing.

It follows a previous report showing that the Werner syndrome protein WRN and its interacting protein WRNIP1 are indispensable for translesion DNA synthesis (TLS) by Y-family DNA polymerases (Pols).

Review Twist Bioscience Corp (TWST:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Review the current Twist Bioscience Corp (TWST:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if TWST is the best investment for you.

DNA synthesis is the biological process by which a deoxyribonucleic acid (DNA) molecule is created. In the cell, each of the two strands of the DNA molecule acts as a template for the synthesis of ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...